Sign In
Buy NVRO
$5.84
+0 (+0%)
At Close: Jul 01, 2025
Nevro to Report Second Quarter 2021 Financial Results
07:00am, Wednesday, 07'th Jul 2021
REDWOOD CITY, Calif., July 7, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain,
Nevro Stock Is Likely To See Higher Levels After A 7% Drop This Week
09:00am, Thursday, 01'st Jul 2021
The stock price of Nevro, a medical devices company, has seen a 7% drop over the last five trading days, despite the company announcing positive findings from its spinal cord stimulation clinical tria
Nevro Announces SENZA-NSRBP Clinical Data Presentation at the American Society of Interventional Pain Physicians 23rd Annual Meeting
06:00am, Tuesday, 22'nd Jun 2021
REDWOOD CITY, Calif., June 22, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain,
Nevro to Host Virtual Analyst & Investor Briefing
07:00am, Monday, 14'th Jun 2021
REDWOOD CITY, Calif., June 14, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain
Why Is Nevro (NVRO) Down 6.3% Since Last Earnings Report?
12:48pm, Friday, 04'th Jun 2021
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Hold on to Nevro (NVRO) Stock Now
03:11pm, Thursday, 13'th May 2021
Investors' confidence is high in Nevro (NVRO) stock, courtesy of its solid prospects.
Nevro Corp. (NVRO) CEO Keith Grossman on Q1 2021 Results - Earnings Call Transcript
02:02pm, Sunday, 09'th May 2021
Nevro Corp. (NVRO) CEO Keith Grossman on Q1 2021 Results - Earnings Call Transcript
Nevro (NVRO) Stock Slips 2.9% Despite Narrower Loss in Q1
12:46pm, Friday, 07'th May 2021
Nevro's (NVRO) international revenues rise on a year-over-year basis in Q1.
Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
07:10pm, Wednesday, 05'th May 2021
Nevro (NVRO) delivered earnings and revenue surprises of 1.16% and 4.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Nevro to Present at UBS Global Healthcare Virtual Conference
07:00am, Tuesday, 27'th Apr 2021
REDWOOD CITY, Calif., April 27, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pai
REDWOOD CITY, Calif., April 26, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that provides innovative, evidence-based solutions for the treatment of chronic pain, t
Nevro Appoints Jon R. Shear as Vice President, Corporate Development
07:00am, Monday, 19'th Apr 2021
REDWOOD CITY, Calif., April 19, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pai
Nevro to Present at BofA Securities 2021 Virtual Health Care Conference
07:00am, Tuesday, 13'th Apr 2021
REDWOOD CITY, Calif., April 13, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pai
Nevro to Report First Quarter 2021 Financial Results
07:00am, Wednesday, 07'th Apr 2021
REDWOOD CITY, Calif., April 7, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain,
Nevro: Harvesting An Epic Growth Opportunity
03:10am, Tuesday, 06'th Apr 2021
Nevro: Harvesting An Epic Growth Opportunity
